| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 02/10/2005 | DE10330842A1 Verwendung der Inhibitoren von Enzymen mit Aktivitäten der Aminopeptidase N und/oder der Dipeptidylpeptidase IV und pharmazeutischen Zubereitungen daraus zur Therapie und Prävention dermatologischer Erkrankungen mit Hyperproliferation und veränderten Differenzierungszuständen von Fibroblasten Use of inhibitors of enzymes with activities of aminopeptidase N and / or of dipeptidyl peptidase IV and pharmaceutical preparations thereof for the treatment and prevention of dermatological diseases with hyperproliferation and altered differentiation states of fibroblasts |
| 02/10/2005 | DE10297513T5 In vitro Herstellung von dendritischen Zellen aus CD14+ Monocyten In vitro production of dendritic cells from CD14 + monocytes |
| 02/10/2005 | CA2534690A1 Composition for the treatment of vitiligo |
| 02/10/2005 | CA2534067A1 Use of a bigaunide derivative for protecting skin against uvb radiation |
| 02/10/2005 | CA2534008A1 Methods of therapeutic treatment using amounts of retinoid components |
| 02/10/2005 | CA2534005A1 Methods of therapeutic treatment using amounts of retinoid components |
| 02/10/2005 | CA2533720A1 Antimycosic nail varnish |
| 02/10/2005 | CA2532894A1 Prebiotically active plant extracts |
| 02/10/2005 | CA2531294A1 2-methylene-19-nor-20(s)-25-methyl-1.alpha.-hydroxycalciferol and its uses |
| 02/09/2005 | EP1505067A1 4,4-disubstituted piperidine derivatives having ccr3 antagonism |
| 02/09/2005 | EP1503996A1 Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors |
| 02/09/2005 | EP1503992A1 Pyridazin-3(2h)-one derivatives as pde4 inhibitors |
| 02/09/2005 | EP1503988A2 Fredericamycin derivatives |
| 02/09/2005 | EP1503800A1 Treatment and prevention of tissue damage |
| 02/09/2005 | EP1503779A2 Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 02/09/2005 | EP1503778A2 Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent |
| 02/09/2005 | EP1503773A1 Hepatoprotective activity of 2 -p-hydroxybenzoylmussaenosidic acid |
| 02/09/2005 | EP1503769A1 Antibiotic/benzoyl peroxide dispenser |
| 02/09/2005 | EP1503767A2 Compositions and methods for treatment of vitamin d deficiency |
| 02/09/2005 | EP1503763A1 Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith |
| 02/09/2005 | EP1503761A1 Substituted piperazines as melanocortin receptor ligands |
| 02/09/2005 | EP1503757A2 Tyrosine kinase inhibitors |
| 02/09/2005 | EP1503752A1 Use of 8-prenylflavanones for anti-angiogenesis therapy and for fibrinolytic therapy |
| 02/09/2005 | EP1503749A2 Methionine aminopeptidase-2 inhibitors and methods of use thereof |
| 02/09/2005 | EP1503735A2 A direct cellular energy delivery system |
| 02/09/2005 | EP1503730A2 Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease |
| 02/09/2005 | EP1503729A1 Composition and the use thereof as a pharmaceutical or cosmetic formulation for external use |
| 02/09/2005 | EP1436252A4 Hydroxyfattysulfonic acid analogs |
| 02/09/2005 | EP1423132A4 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 02/09/2005 | EP1390031B1 Topical composition containing a fungicide |
| 02/09/2005 | EP1385854B1 Thiazolopyrimidines and their use as modulators of chemokine receptor activity |
| 02/09/2005 | EP1299059A4 Method and manufacture of a wound dressing for covering an open wound |
| 02/09/2005 | EP1284601A4 Allantoin-containing skin cream |
| 02/09/2005 | EP1150960B1 Polymorphic crystalline forms of celecoxib |
| 02/09/2005 | EP1140939B1 Substituted 2-aryl-3-(heteroaryl)-imidazo[1,2-alpha]pyrimidines, and related pharmaceutical compositions and methods |
| 02/09/2005 | EP1079813B1 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 02/09/2005 | EP1071417B1 Use of cannabidiol as anti-inflammatory agent |
| 02/09/2005 | CN2676917Y 壳聚糖药膜 Chitosan film with |
| 02/09/2005 | CN1578786A Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 02/09/2005 | CN1578779A Small organic molecule regulators of cell proliferation |
| 02/09/2005 | CN1578776A Heterocyclic retinoid compounds |
| 02/09/2005 | CN1578768A Anthranilic acid amides and pharmaceutical use thereof |
| 02/09/2005 | CN1578767A Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient |
| 02/09/2005 | CN1578688A Method and apparatus for the photomodulation of living cells |
| 02/09/2005 | CN1578672A Rsv基因表达疫苗 Rsv gene expression vaccine |
| 02/09/2005 | CN1578670A Use of lactalapoprotein in prevention and treatment of microbial or virus infection |
| 02/09/2005 | CN1578665A Type 4 phosphodiesterase inhibitors and uses thereof |
| 02/09/2005 | CN1578661A Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 02/09/2005 | CN1578653A Cosmetics and treatment method for promoting maturation of cornified envelopes |
| 02/09/2005 | CN1578626A Multivesicular emulsion topical delivery systems |
| 02/09/2005 | CN1575806A Acne treating agent |
| 02/09/2005 | CN1575805A Scarless wound healing ointment |
| 02/09/2005 | CN1575804A Pure Chinese herbal medicine ointment for treating skin ulcer |
| 02/09/2005 | CN1188410C Nonsteroid IL-5 inhibitor, its preparation method and medical composition containing the same inhibitor |
| 02/09/2005 | CN1188404C Cyclic compound |
| 02/09/2005 | CN1188388C Aminobenzophenones as inhibitors of interleukin and TNF |
| 02/09/2005 | CN1188166C Drug for treating skin disease and preparation method thereof |
| 02/09/2005 | CN1188164C Compositions and method for regulating phagocytosis and ICAM-1 expression |
| 02/09/2005 | CN1188154C Quick-acting antalgesic-antipruritic tincture and preparing method thereof |
| 02/09/2005 | CN1188144C Medicine for curing human body burns and scalds |
| 02/09/2005 | CN1188140C Reduction of oxidative stress factors |
| 02/09/2005 | CN1188132C Medicine for inhibiting and killing body's superficial pathogenic fungi |
| 02/09/2005 | CN1188119C Method of reducing appearance of black colour at lower part of eye |
| 02/09/2005 | CN1188104C Hair-growing liquid |
| 02/08/2005 | US6852751 Difluorobutyric acid metalloprotease inhibitors |
| 02/08/2005 | US6852747 Resorcinol derivatives |
| 02/08/2005 | US6852740 Treating p38 kinase mediated disorders. Compounds of particular interest are defined by Formula I Mitogen-activated protein kinases (MAP) is a family of proline- directed serine/threonine kinases that activate their |
| 02/08/2005 | US6852738 Potent ligands for PPAR gamma and generally have antagonist or partial agonist activity. The compoundsare for treatment, control or prevention of obesity, non-insulin dependent diabetes mellitus (NIDDM), hyperglycemia, dyslipidemia, |
| 02/08/2005 | US6852736 Phenoxypropanolamines, preparation and therapeutic use thereof |
| 02/08/2005 | US6852734 Indole wherein A is an oxygen atom or a nitrogen atom which nitrogen atom is optionally substituted with an alkyl group, and (i) R1 and R2 each stand for a hydrogen atom or an alkyl group, independently, or (ii) R1 and R2 as taken together form |
| 02/08/2005 | US6852732 A tetrahydropyridino or piperidino heterocyclic derivative represented by the formula (I): has a high affinity for CRF receptors and is effective against diseases in which CRF is considered to be involved. (Corticotropin releasing factor |
| 02/08/2005 | US6852727 Inhibitors of Janus protein tyrosine kinases (Jak), and as such are useful as immunosuppressants, and in the treatment of diseases including asthma, allergies, autoimmune diseases. |
| 02/08/2005 | US6852725 Imidazolyl derivatives |
| 02/08/2005 | US6852717 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor; for use in therapy of diseases and pathological conditions involving inflammation such as chronic inflammatory disease |
| 02/08/2005 | US6852712 Controlling cell differentiation; antiinflammatory agents |
| 02/08/2005 | US6852533 For making vectors for gene therapy |
| 02/08/2005 | US6852518 Glycosyl sulfotransferases GST-4α, GST-4β, and GST-6 |
| 02/08/2005 | US6852343 Antiadipose topical treatment composition based on garlic bulbs extracts, and cosmetic and therapeutic uses |
| 02/08/2005 | US6852326 DHEA (dehydroepiandrosterone); for use on human skin treating wrinkles, UV radiation damage, aging |
| 02/08/2005 | CA2164050C Cosmetic compositions containing betulinic acid |
| 02/03/2005 | WO2005010047A2 Antiangiogenic compounds, pharmaceutical composition containing said compounds and the use thereof |
| 02/03/2005 | WO2005010027A2 Novel peptidic conjugates for alopecia preventive and curative treatment |
| 02/03/2005 | WO2005009992A1 Cyclohexanecarboxylic acid compound |
| 02/03/2005 | WO2005009938A2 Dibenzoilmethane derivative compounds, the use thereof in the form of photoactivable solar filters and cosmetic compositions containing said compounds |
| 02/03/2005 | WO2005009473A1 Antifungal aerosol external preparation |
| 02/03/2005 | WO2005009461A1 Factor vii activating protease (fsap) polypeptides for the treatment of angiogenesis-related disorders |
| 02/03/2005 | WO2005009458A1 Use of xmp-629 for the treatment of acne |
| 02/03/2005 | WO2005009456A2 Use of peptidic conjugates for preparing compositions for alopecia preventive and curative treatment |
| 02/03/2005 | WO2005009427A1 Curative medicine for allergosis |
| 02/03/2005 | WO2005009406A1 Topical skin care composition containing refined peanut oil |
| 02/03/2005 | WO2005009331A2 Use of a cosmetic or pharmaceutical composition, comprising a lupeol-rich extract as an active ingredient for stimulating the synthesis of heat shock proteins |
| 02/03/2005 | WO2005009276A2 Microbial cellulose wound dressing |
| 02/03/2005 | WO2004087202A3 Pharmaceutical composition comprising a macrolide immunomodulator |
| 02/03/2005 | WO2004078122A3 Invisible patch for active agnet controlled delivery |
| 02/03/2005 | WO2004002416A3 Methods and materials for treating human papillomavirus infections |
| 02/03/2005 | WO2003094859A3 Epha2 monoclonal antibodies and methods of use thereof |
| 02/03/2005 | WO2002096360A3 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals |
| 02/03/2005 | US20050027114 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 02/03/2005 | US20050027016 Polyamine compounds and compositions for use in conjection with cancer therapy |
| 02/03/2005 | US20050027013 LTA4 hydrolase inhibitors |